| Goel, Ajay |
Beckman Research Institute/City Of Hope
United States |
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer |
5U01CA214254-05 |
|
Sharmistha Ghosh-Janjigian, Ph.D. |
| Goel, Ajay |
Beckman Research Institute/City Of Hope
United States |
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer |
5R01CA227602-04 |
PAR-16-276 (R01) |
Matthew Young, Ph.D. |
| Goggins, Michael G. |
Johns Hopkins University
United States |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
2U01CA210170-06 |
PAR-21-334 (U01 Clinical Trial Optional) |
Sharmistha Ghosh-Janjigian, Ph.D. |
| Goggins, Michael G. |
Johns Hopkins University
United States |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
2U01CA210170-06 |
PAR-21-334 (U01 Clinical Trial Optional) |
Sharmistha Ghosh-Janjigian, Ph.D. |
| Goggins, Michael G. |
Johns Hopkins University
United States |
Using Markers to Improve Pancreatic Cancer Screening |
5R01CA176828-08 |
|
Jo Ann Rinaudo, Ph.D. |
| Goldman, Radoslav |
Georgetown University
United States |
O-glycoproteins in the progression of liver disease |
5R01CA238455-04 |
|
Jo Ann Rinaudo, Ph.D. |
| Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states. |
6R01CA220004-06 |
|
Matthew Young, Ph.D. |
| Grady, William Mallory |
Fred Hutchinson Cancer Center
United States |
Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome |
1U54CA274374-01 |
RFA-CA-21-054 (U54 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |
| Grimm, Lars J |
Duke University
United States |
Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications |
1R01CA271237-01 |
PAR-19-264 (R01 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |
| Grimm, Lars J |
Duke University
United States |
Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications |
1R01CA271237-01 |
PAR-19-264 (R01 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |